Technicals for GlaxoSmithKline Pharmaceuticals Limited
The BOLL BANDS is showing a neutral stance, with no definitive indication...
The BOLL BANDS is showing a neutral stance, with no definitive indication...
Investors may react cautiously to news that GLAXO's revenues are forecasted to...
The list of all important regulatory filings for GlaxoSmithKline Pharmaceuticals Limited which...
The article analyzes recent trends in the yield and convenience of U.S....
An analysis of WFH Research’s monthly time-series data on remote work trends,...
Analysis of the St. Louis Fed’s view that economic education strengthens monetary...
Published | Title | Summary |
---|---|---|
2025-01-20 15:40:54 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
2025-01-15 12:39:50 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
2024-07-22 13:05:12 | Board Meeting Intimation | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting... |
2024-05-17 14:11:26 | Record Date | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date... |
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Lists of companies in NSE500 with the best and the worst technicals...
This article delves into the critical need for reform in public spending...
The article provides an in-depth analysis of the economic landscape in the...
An analysis of South Asia's economic trajectory focusing on the potential of...